Rather than to prove the broader pathophysiological role of CP in serious liver disease, we hypothesized that CP can be applied effectively as a biomarker to help improve the non-invasive diagnosis of liver fibrosis in CHB patients and predict progression to cirrhosis. The gene discussed is CP; the disease is Hepatic fibrosis.